BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17513288)

  • 1. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Ho S; Lukacs Z; Hoffmann GF; Lindner M; Wetter T
    Clin Chem; 2007 Jul; 53(7):1330-7. PubMed ID: 17513288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data mining methods for classification of Medium-Chain Acyl-CoA dehydrogenase deficiency (MCADD) using non-derivatized tandem MS neonatal screening data.
    Van den Bulcke T; Vanden Broucke P; Van Hoof V; Wouters K; Vanden Broucke S; Smits G; Smits E; Proesmans S; Van Genechten T; Eyskens F
    J Biomed Inform; 2011 Apr; 44(2):319-25. PubMed ID: 21167313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain acyl-CoA dehydrogenase deficiency in Saudi Arabia: incidence, genotype, and preventive implications.
    Al-Hassnan ZN; Imtiaz F; Al-Amoudi M; Rahbeeni Z; Al-Sayed M; Al-Owain M; Al-Zaidan H; Al-Odaib A; Rashed MS
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S263-7. PubMed ID: 20567907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supervised machine learning techniques for the classification of metabolic disorders in newborns.
    Baumgartner C; Böhm C; Baumgartner D; Marini G; Weinberger K; Olgemöller B; Liebl B; Roscher AA
    Bioinformatics; 2004 Nov; 20(17):2985-96. PubMed ID: 15180934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal medium-chain acyl-CoA dehydrogenase deficiency identified by newborn screening.
    Leydiker KB; Neidich JA; Lorey F; Barr EM; Puckett RL; Lobo RM; Abdenur JE
    Mol Genet Metab; 2011 May; 103(1):92-5. PubMed ID: 21354840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
    Tan J; Chen D; Huang J; Chang R; Yan T; Cai R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Nov; 36(11):1067-1072. PubMed ID: 31703127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan.
    Shigematsu Y; Hirano S; Hata I; Tanaka Y; Sudo M; Sakura N; Tajima T; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):39-48. PubMed ID: 12127323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.
    Dezateux C
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S25-8. PubMed ID: 14628139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Najdekr L; Gardlo A; Mádrová L; Friedecký D; Janečková H; Correa ES; Goodacre R; Adam T
    Talanta; 2015 Jul; 139():62-6. PubMed ID: 25882409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.
    Schulze A; Lindner M; Kohlmüller D; Olgemöller K; Mayatepek E; Hoffmann GF
    Pediatrics; 2003 Jun; 111(6 Pt 1):1399-406. PubMed ID: 12777559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening and genetic variation of medium chain acyl-CoA dehydrogenase deficiency in the Chinese population.
    Li YY; Xu J; Sun XC; Li HY; Mu K
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1264-1271. PubMed ID: 36068006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.
    Goddard P
    J Fam Health Care; 2004; 14(4):90-2. PubMed ID: 15453442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany.
    Hoffmann GF; von Kries R; Klose D; Lindner M; Schulze A; Muntau AC; Röschinger W; Liebl B; Mayatepek E; Roscher AA
    Eur J Pediatr; 2004 Feb; 163(2):76-80. PubMed ID: 14714182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid diagnosis of medium chain Acyl Co-A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry.
    la Marca G; Malvagia S; Donati MA; Morrone A; Pasquini E; Zammarchi E
    Rapid Commun Mass Spectrom; 2003; 17(23):2688-92. PubMed ID: 14648909
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
    Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Maier EM; Liebl B; Röschinger W; Nennstiel-Ratzel U; Fingerhut R; Olgemöller B; Busch U; Krone N; v Kries R; Roscher AA
    Hum Mutat; 2005 May; 25(5):443-52. PubMed ID: 15832312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker discovery, disease classification, and similarity query processing on high-throughput MS/MS data of inborn errors of metabolism.
    Baumgartner C; Baumgartner D
    J Biomol Screen; 2006 Feb; 11(1):90-9. PubMed ID: 16314408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.